Westlake Chemical Partners LP acquires, develops and operates ethylene production facilities and related assets in the United States. The company is headquartered in Houston, Texas.
67 articles
Westlake Chemical Partners shares rose above the 50-day moving average to $21.70, though analysts cite mixed sentiment due to missed EPS and high payout ratios.
Westlake Chemical Partners stock traded below its 200-day moving average at $21.5150, maintaining a Moderate Buy consensus among analysts. The company also announced a quarterly dividend of $0.4714 pe
Westlake Chemical Partners LP stock analysis indicates strong long-term prospects with a 6.3% gain target, utilizing AI models for risk allocation across three institutional trading strategies.
Westlake Chemical Partners projects 6.9% annual revenue growth and 9.7% EPS growth, while analysts lowered the price target to $26.00 citing dividend sustainability concerns.
Wall Street Zen downgraded Westlake Chemical Partners to Hold, while Weiss Ratings upgraded it to Buy. The company significantly missed revenue estimates, reporting $297.1 million against $537 million
Westlake Chemical Partners LP director G. Stephen Finley acquired 5,044 phantom units on August 12, 2026, per a Form 4 filing. The units are economically equivalent to common shares and exercisable st
Westlake Chemical Partners Director Lisa A. Friel acquired 5,044 phantom units on August 12, 2026, according to a Form 4 filing. These cost-free units are equivalent to common units and become exercis
Westlake Chemical Partners LP granted director Finley G. Stephen 5,044 phantom units as compensation on August 12, 2026. The award has an exercise date of August 12, 2027.
Westlake Chemical Partners reported Q2 2026 net income of $14 million, supported by its fixed-margin Ethylene Sales Agreement. Management discussed extending credit agreements and announced a finance
Westlake Chemical Partners reported Q2 2026 net income of $14 million and maintained its quarterly distribution for the 48th consecutive period. Fixed-margin Ethylene Sales Agreements were cited as ke
Westlake Chemical Partners reported Q2 2026 net income of $14.2 million, extended credit facilities to July 2031, and maintained its quarterly distribution. Stability relies on a long-term ethylene sa
Stephen G. Finley, director of Westlake Chemical Partners GP LLC, converted 5,005 phantom units into common units on August 6, increasing his direct holdings to 36,935.
Westlake Chemical Partners LP reported steady Q2 performance with flat net income but increased distributable cash flow. The partnership emphasizes reliable distributions and conservative leverage tie
Westlake Chemical Partners LP posted Q2 net income of $14.2 million and revenue of $297.1 million. The Houston-based ethylene producer disclosed these figures via Zacks Investment Research.
Westlake Chemical Partners extended credit facilities to July 2031 and maintained its quarterly distribution at $0.4714 per unit following Q2 2026 net income of $14.2 million.
Westlake Chemical Partners reported quarterly earnings of $0.40 per share, missing estimates by $0.01, with revenue falling short at $297.1 million against a $537 million forecast.
Westlake Chemical Partners LP reported $14 million net income in Q2 2026, supported by stable production and fixed-margin ethylene sales. The company plans to maintain distributions while pursuing gro
Westlake Chemical Partners reported Q2 2026 earnings of $0.40 per unit on $297.1 million revenue, missing analyst estimates but increasing distributable cash flow by 20%. Stable financial metrics were
Westlake Chemical Partners LP reported second-quarter 2026 revenue of $297.1 million, missing Wall Street forecasts, although distributable cash flow improved to $17.6 million while maintaining its qu
Westlake Chemical Partners LP reported second-quarter earnings per share of $0.40, missing analyst estimates, while revenue dropped to $297.1 million against a consensus of $537 million.
Westlake Chemical Partners LP reported Q2 2026 earnings missing analyst expectations, posting $14.2 million net income on $297.1 million revenue despite a positive analyst outlook.
Westlake Chemical Partners reported Q2 2026 net income of $14.2 million and declared its 48th consecutive quarterly distribution of $0.4714 per unit. Operating cash flow rose significantly while credi
Westlake Chemical Partners LP reported Q2 2026 net income of $14.2 million, down slightly from the prior year, while operating cash flow rose to $129.8 million. The company maintained its quarterly di
Westlake Chemical Partners LP reported Q2 net income of $0.40 per unit and revenue of $297.1 million. The company operates ethylene production facilities with a total annual capacity of approximately
Westlake Chemical Partners LP reported second-quarter 2026 revenue of $297.1 million. The company operates ethylene production facilities and pipelines across Kentucky and Louisiana with an annual cap
Stock Traders Daily releases a precision trading analysis for Westlake Chemical Partners LP (WLKP), outlining neutral sentiment, risk zones, and institutional strategies.
Westlake Chemical Partners announced it will webcast its Q2 earnings discussion on August 4, offering financial updates on the NYSE-listed chemical firm.
Financial data for Westlake Chemical Partners LP indicates that the Enterprise Value to EBITDA forward metric is currently unavailable, showing no trades or period value change.
Westlake Chemical Partners LP reports strong financial metrics including a 30.67% gross margin and 26.71% net margin. With a $784.57M market cap, it maintains a leading sector position while outperfor
Westlake Chemical Partners (WLKP) exhibits neutral near-term trends with a potential long-term positive bias. The analysis highlights a 28.2:1 risk-reward setup targeting a 7.6% gain via AI-generated
ChemBrief